ClinicalTrialsFinder

Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia Clinical Trials in New Haven, Connecticut

1 recruitingNew Haven, Connecticut

Showing 1–1 of 1 trials

Recruiting
Phase 1

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Acute Myeloid LeukemiaMyelodysplastic SyndromeRecurrent Myelodysplastic Syndrome+6 more
National Cancer Institute (NCI)54 enrolled21 locationsNCT06484062